As of Feb 24
| -0.56 / -0.45%|
The 7 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 160.00, with a high estimate of 208.00 and a low estimate of 135.00. The median estimate represents a +29.30% increase from the last price of 123.74.
The current consensus among 7 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.